- Home
- CRNT vs IMRX Comparison
CRNT vs IMRX Comparison
Compare CRNT & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNT
- IMRX
- Stock Information
- Founded
- CRNT 1996
- IMRX 2008
- Country
- CRNT Israel
- IMRX United States
- Employees
- CRNT N/A
- IMRX N/A
- Industry
- CRNT Radio And Television Broadcasting And Communications Equipment
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- CRNT Technology
- IMRX Health Care
- Exchange
- CRNT Nasdaq
- IMRX Nasdaq
- Market Cap
- CRNT 228.3M
- IMRX 232.9M
- IPO Year
- CRNT 2000
- IMRX 2021
- Fundamental
- Price
- CRNT $2.60
- IMRX $6.87
- Analyst Decision
- CRNT Strong Buy
- IMRX Strong Buy
- Analyst Count
- CRNT 4
- IMRX 5
- Target Price
- CRNT $5.50
- IMRX $17.20
- AVG Volume (30 Days)
- CRNT 669.3K
- IMRX 1.4M
- Earning Date
- CRNT 11-11-2025
- IMRX 11-10-2025
- Dividend Yield
- CRNT N/A
- IMRX N/A
- EPS Growth
- CRNT 34.68
- IMRX N/A
- EPS
- CRNT 0.15
- IMRX N/A
- Revenue
- CRNT $380,518,000.00
- IMRX N/A
- Revenue This Year
- CRNT N/A
- IMRX N/A
- Revenue Next Year
- CRNT $7.23
- IMRX N/A
- P/E Ratio
- CRNT $17.41
- IMRX N/A
- Revenue Growth
- CRNT 5.06
- IMRX N/A
- 52 Week Low
- CRNT $1.82
- IMRX $1.10
- 52 Week High
- CRNT $5.73
- IMRX $10.08
- Technical
- Relative Strength Index (RSI)
- CRNT 58.03
- IMRX 57.97
- Support Level
- CRNT $2.48
- IMRX $6.10
- Resistance Level
- CRNT $2.84
- IMRX $5.92
- Average True Range (ATR)
- CRNT 0.13
- IMRX 0.48
- MACD
- CRNT 0.01
- IMRX 0.09
- Stochastic Oscillator
- CRNT 54.82
- IMRX 90.11
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.